Loading…
MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex
The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifi...
Saved in:
Published in: | Pharmacological reports 2013-09, Vol.65 (5), p.1112-1123 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73 |
---|---|
cites | cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73 |
container_end_page | 1123 |
container_issue | 5 |
container_start_page | 1112 |
container_title | Pharmacological reports |
container_volume | 65 |
creator | Maćkowiak, Marzena Guzik, Rafał Dudys, Dorota Bator, Ewelina Wędzony, Krzysztof |
description | The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression.
Stereological counting, immunoblot analysis and confocal laser scanning microscopy.
Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis.
Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis. |
doi_str_mv | 10.1016/S1734-1140(13)71469-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490705577</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1734114013714695</els_id><sourcerecordid>1490705577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</originalsourceid><addsrcrecordid>eNqFkU9PHCEYh0ljU7e2H6ENR02clpc_w8zJGK3aVNtD2zNh2XdczCyMwBr99rKuevVAIOH5_YAHQr4A-wYM2u9_QQvZAEi2D-JAg2z7Rr0jM877umg7uUNmr8gu-ZjzDWMSuFAfyC6Xou810zMSr341HYNDaunvq9NjmtDhVGKiNhR7HYPP5ZD64BLajJlOy5jrSA-jLT4GGge6rEgMSC9E5WhZIk220BUuvB3plHBIsVaN1MVU8P4TeT_YMePn53mP_D_78e_korn8c_7z5PiycVJ3peGw6CxHPXRSKN5K6yRnLcd5C3LohWZMDKC0mLsFSAvoFHOsFRIHx2SPWuyR_W3vlOLtGnMxK58djqMNGNfZgOyZZkrpDaq2qEsx53phMyW_sunBADMb1-bJtdmINCDMk2ujau7r8xHreX3ua-pFbgXaLZDrVrjGZG7iOoX67Debj7ZBrIbufA1m5zG46rT-TzGL6N9oeARHTZ22</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490705577</pqid></control><display><type>article</type><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><source>Elsevier ScienceDirect Journals</source><source>Springer Link</source><creator>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</creator><creatorcontrib>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</creatorcontrib><description>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression.
Stereological counting, immunoblot analysis and confocal laser scanning microscopy.
Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis.
Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</description><identifier>ISSN: 1734-1140</identifier><identifier>EISSN: 2299-5684</identifier><identifier>DOI: 10.1016/S1734-1140(13)71469-5</identifier><identifier>PMID: 24399707</identifier><language>eng</language><publisher>Cham: Elsevier Urban & Partner Sp. z o.o</publisher><subject>Acetylation ; Animals ; Antipsychotic Agents - pharmacology ; Chromatin Assembly and Disassembly - drug effects ; Dizocilpine Maleate - toxicity ; Drug Safety and Pharmacovigilance ; epigenetics ; Excitatory Amino Acid Antagonists - toxicity ; Gene Expression Regulation - drug effects ; histone 3 ; Histones - metabolism ; Lysine ; Male ; medial prefrontal cortex ; MK-801 ; Pharmacotherapy ; Pharmacy ; Phenotype ; Phosphorylation ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Protein Processing, Post-Translational - drug effects ; Psychoses, Substance-Induced - genetics ; Psychoses, Substance-Induced - metabolism ; Psychoses, Substance-Induced - prevention & control ; psychosis ; Pyramidal Cells - drug effects ; Pyramidal Cells - metabolism ; pyramidal neurons ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors ; Receptors, N-Methyl-D-Aspartate - metabolism ; Risperidone - pharmacology ; schizophrenia ; Serine ; Time Factors</subject><ispartof>Pharmacological reports, 2013-09, Vol.65 (5), p.1112-1123</ispartof><rights>2013 Institute of Pharmacology Polish Academy of Sciences</rights><rights>Maj Institute of Pharmacology, Polish Academy of Sciences 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</citedby><cites>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1734114013714695$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24399707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maćkowiak, Marzena</creatorcontrib><creatorcontrib>Guzik, Rafał</creatorcontrib><creatorcontrib>Dudys, Dorota</creatorcontrib><creatorcontrib>Bator, Ewelina</creatorcontrib><creatorcontrib>Wędzony, Krzysztof</creatorcontrib><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><title>Pharmacological reports</title><addtitle>Pharmacol. Rep</addtitle><addtitle>Pharmacol Rep</addtitle><description>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression.
Stereological counting, immunoblot analysis and confocal laser scanning microscopy.
Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis.
Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</description><subject>Acetylation</subject><subject>Animals</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Chromatin Assembly and Disassembly - drug effects</subject><subject>Dizocilpine Maleate - toxicity</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>epigenetics</subject><subject>Excitatory Amino Acid Antagonists - toxicity</subject><subject>Gene Expression Regulation - drug effects</subject><subject>histone 3</subject><subject>Histones - metabolism</subject><subject>Lysine</subject><subject>Male</subject><subject>medial prefrontal cortex</subject><subject>MK-801</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><subject>Phenotype</subject><subject>Phosphorylation</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Protein Processing, Post-Translational - drug effects</subject><subject>Psychoses, Substance-Induced - genetics</subject><subject>Psychoses, Substance-Induced - metabolism</subject><subject>Psychoses, Substance-Induced - prevention & control</subject><subject>psychosis</subject><subject>Pyramidal Cells - drug effects</subject><subject>Pyramidal Cells - metabolism</subject><subject>pyramidal neurons</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>Risperidone - pharmacology</subject><subject>schizophrenia</subject><subject>Serine</subject><subject>Time Factors</subject><issn>1734-1140</issn><issn>2299-5684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkU9PHCEYh0ljU7e2H6ENR02clpc_w8zJGK3aVNtD2zNh2XdczCyMwBr99rKuevVAIOH5_YAHQr4A-wYM2u9_QQvZAEi2D-JAg2z7Rr0jM877umg7uUNmr8gu-ZjzDWMSuFAfyC6Xou810zMSr341HYNDaunvq9NjmtDhVGKiNhR7HYPP5ZD64BLajJlOy5jrSA-jLT4GGge6rEgMSC9E5WhZIk220BUuvB3plHBIsVaN1MVU8P4TeT_YMePn53mP_D_78e_korn8c_7z5PiycVJ3peGw6CxHPXRSKN5K6yRnLcd5C3LohWZMDKC0mLsFSAvoFHOsFRIHx2SPWuyR_W3vlOLtGnMxK58djqMNGNfZgOyZZkrpDaq2qEsx53phMyW_sunBADMb1-bJtdmINCDMk2ujau7r8xHreX3ua-pFbgXaLZDrVrjGZG7iOoX67Debj7ZBrIbufA1m5zG46rT-TzGL6N9oeARHTZ22</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Maćkowiak, Marzena</creator><creator>Guzik, Rafał</creator><creator>Dudys, Dorota</creator><creator>Bator, Ewelina</creator><creator>Wędzony, Krzysztof</creator><general>Elsevier Urban & Partner Sp. z o.o</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><author>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetylation</topic><topic>Animals</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Chromatin Assembly and Disassembly - drug effects</topic><topic>Dizocilpine Maleate - toxicity</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>epigenetics</topic><topic>Excitatory Amino Acid Antagonists - toxicity</topic><topic>Gene Expression Regulation - drug effects</topic><topic>histone 3</topic><topic>Histones - metabolism</topic><topic>Lysine</topic><topic>Male</topic><topic>medial prefrontal cortex</topic><topic>MK-801</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><topic>Phenotype</topic><topic>Phosphorylation</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Protein Processing, Post-Translational - drug effects</topic><topic>Psychoses, Substance-Induced - genetics</topic><topic>Psychoses, Substance-Induced - metabolism</topic><topic>Psychoses, Substance-Induced - prevention & control</topic><topic>psychosis</topic><topic>Pyramidal Cells - drug effects</topic><topic>Pyramidal Cells - metabolism</topic><topic>pyramidal neurons</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>Risperidone - pharmacology</topic><topic>schizophrenia</topic><topic>Serine</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maćkowiak, Marzena</creatorcontrib><creatorcontrib>Guzik, Rafał</creatorcontrib><creatorcontrib>Dudys, Dorota</creatorcontrib><creatorcontrib>Bator, Ewelina</creatorcontrib><creatorcontrib>Wędzony, Krzysztof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maćkowiak, Marzena</au><au>Guzik, Rafał</au><au>Dudys, Dorota</au><au>Bator, Ewelina</au><au>Wędzony, Krzysztof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</atitle><jtitle>Pharmacological reports</jtitle><stitle>Pharmacol. Rep</stitle><addtitle>Pharmacol Rep</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>65</volume><issue>5</issue><spage>1112</spage><epage>1123</epage><pages>1112-1123</pages><issn>1734-1140</issn><eissn>2299-5684</eissn><abstract>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression.
Stereological counting, immunoblot analysis and confocal laser scanning microscopy.
Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis.
Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</abstract><cop>Cham</cop><pub>Elsevier Urban & Partner Sp. z o.o</pub><pmid>24399707</pmid><doi>10.1016/S1734-1140(13)71469-5</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1734-1140 |
ispartof | Pharmacological reports, 2013-09, Vol.65 (5), p.1112-1123 |
issn | 1734-1140 2299-5684 |
language | eng |
recordid | cdi_proquest_miscellaneous_1490705577 |
source | Elsevier ScienceDirect Journals; Springer Link |
subjects | Acetylation Animals Antipsychotic Agents - pharmacology Chromatin Assembly and Disassembly - drug effects Dizocilpine Maleate - toxicity Drug Safety and Pharmacovigilance epigenetics Excitatory Amino Acid Antagonists - toxicity Gene Expression Regulation - drug effects histone 3 Histones - metabolism Lysine Male medial prefrontal cortex MK-801 Pharmacotherapy Pharmacy Phenotype Phosphorylation Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Protein Processing, Post-Translational - drug effects Psychoses, Substance-Induced - genetics Psychoses, Substance-Induced - metabolism Psychoses, Substance-Induced - prevention & control psychosis Pyramidal Cells - drug effects Pyramidal Cells - metabolism pyramidal neurons Rats Rats, Wistar Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Receptors, N-Methyl-D-Aspartate - metabolism Risperidone - pharmacology schizophrenia Serine Time Factors |
title | MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MK-801,%20a%20NMDA%20receptor%20antagonist,%20increases%20phosphorylation%20of%20histone%20H3%20in%20the%20rat%20medial%20prefrontal%20cortex&rft.jtitle=Pharmacological%20reports&rft.au=Ma%C4%87kowiak,%20Marzena&rft.date=2013-09-01&rft.volume=65&rft.issue=5&rft.spage=1112&rft.epage=1123&rft.pages=1112-1123&rft.issn=1734-1140&rft.eissn=2299-5684&rft_id=info:doi/10.1016/S1734-1140(13)71469-5&rft_dat=%3Cproquest_cross%3E1490705577%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490705577&rft_id=info:pmid/24399707&rfr_iscdi=true |